Stromal Vascular Fraction Obtained From Subcutaneous Adipose Tissue: Ex-Obese and Older Population as Main Clinical Targets

Autores da FMUP

• Ricardo José Moreira Horta Oliveira

  Autor

Participantes de fora da FMUP

• Frias, F
• Matos, B
• Jarnalo, M
• Freitas Ribeiro, S
• Reis, RL
• Pirraco, RP

Unidades de investigação

• Cirurgia e Fisiologia

Abstract

Introduction: Human adipose tissue contains a heterogeneous and synergistic mixture of cells called stromal vascular fraction (SVF) with highly proliferative and angiogenic properties, conferring promising applicability in the field of regenerative medicine. This study aims to investigate if age, body mass index (BMI), history of obesity and massive weight loss, and harvest site are related to SVF cell marker expression. Methods: A total of 26 samples of subcutaneous adipose tissue were harvested from patients admitted to the Plastic and Reconstructive department in University Hospital Center of S?o Jo?o, Porto, Portugal, for body contouring surgery. The percentage of cells expressing CD31, CD34, CD45, CD73, CD90, and CD105 was assessed and compared with patients age, BMI, history of obesity and massive weight loss (ex-obese group), and harvest site. Results: In the ex-obese group, a significantly higher number of cells expressing CD90 (P = 0.002) was found. BMI, harvest site, and age appear to have no association with SVF subpopulations. Conclusions: This study suggests that ex-obese patients have a higher percentage of SVF cells expressing CD90, which correlates with higher proliferative and angiogenic rates. The effect of former obesity and massive weight loss on the expression of CD90 is a new and relevant finding because it makes this population a suitable candidate for reconstructive and aesthetic surgery and other fields of regenerative medicine. The use of SVF appears also promising in older patients because no negative correlation between increasing age and different cell markers expression was found. ? 2022 Elsevier Inc.

Keywords

• Adipose-derived stem cells; CD90; Regenerative medicine; Stromal vascular fraction